Tegridy Value LP

[whatstheofficerproblem]

I think they win. Lot of good posts in the LQDA thread.

[nafregnum]

I'm just about to put some Micron profits in LQDA, trying to decide between $55 Jan'27 calls, $55 Jan'28 calls or just buying and holding.

[whatstheofficerproblem]

Depends on your conviction in the case AND timeline. If you think we get a favorable judgement before 2H26, then the Jan 27s have very juicy r/r assuming stock goes above $100. If you want less risk and more duration, say judge might not rule this year and might not rule favorably, then 28s will get you through the tougher times if they exist. 

 

I you want to say, I'm good and I don't need to worry about all that, then just buy the underlying and collect option premium like @lnofeisone.

 

I personally think we get a favorable decision before August. Hence put all my money in Jan 27s. I also think we see a step function change i.e. acceleration in revenues for Yutrepia right about starting 1Q26 which will be reported next week as this was the timeline for organic DPI inflection at UTHR. Should help the stock break past where it is range bound right now.

 

A bad UTHR print tomorrow morning will also certainly help.

[nafregnum]

Uh oh, I should've been more on the ball and bought them today.  I actually clicked the button on the options but hadn't realized it was a few minutes past market close, so I'll probably be kicking myself tomorrow morning.

[whatstheofficerproblem]

8 minutes ago, nafregnum said:

Uh oh, I should've been more on the ball and bought them today.  I actually clicked the button on the options but hadn't realized it was a few minutes past market close, so I'll probably be kicking myself tomorrow morning.

 

Don't lose sleep over it. I could have got my contracts for a few cents cheaper had I not thought we would have gotten a ruling by end of March and rushed to buy the calls. 

[moatrep]

There is the theory UTHR will post the last bullshit, so we will see if we can get some price. Lqda reports 11th.

[whatstheofficerproblem]

As 3Q26 edges closer, Tegridy is up ~25% as of today's close (5/6). I know not if this will last by end of the quarter, but who knew running our own play pretend fund could be so fun.

[moatrep]

Have you looked at Harrow? Looks like they are talking about 750m in revenue for 28, and mkap is 1.15b. Growing at >25% cagr. And with new lines also coming after 28. Some people I respect are talking about it as a candidate for multi bagger Just got intriged and wondering if you are following. Thanks!

Edited May 18 by moatrep

[whatstheofficerproblem]

8 minutes ago, moatrep said:

Have you looked at Harrow? Looks like they are talking about 750m in revenue for 28, and mkap is 1.15b. Growing at >25% cagr. And with new lines also coming after 28. Some people I respect are talking about it as a candidate for multi bagger Just got intriged and wondering if you are following. Thanks!

 

Haven't looked at Harrow. I am not a biotech specialist in that I don't have a PhD or depth on broader topics. Casting a wider net here when it's not your core competence and looking at more than the typical 3-4 names would imo work against you. The nature of this sector is that it's very hit or miss. You'd be risking 50% to gain 10% or even lose 10% more even on good data. You need to be a masochist to enjoy biotech and that is simply not my thing. Will likely start looking around when LQDA/INBX play out.